Drawing for SCRIPS ELIXERS

USPTO serial 76525066

SCRIPS ELIXERS

Reviewed by CopyMark Law Group

Status 614
Filing date
Status date
Registration date
—
Examiner
DALIER, LAURIEL
Law office
PETITIONS OFFICE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SCRIPS ELIXERS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Margaret Poison

MARGARET POISON PATENT LAW OFFICES OF RICK MARTIN, PC416 COFFMAN STLONGMONT, CO 80501UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Retail drug stores servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 3, 2006PETDPETITION TO REVIVE-DENIED—
Feb 15, 2005PETRPETITION TO REVIVE-RECEIVED—
Feb 15, 2005FAXXFAX RECEIVED—
Sep 6, 2004ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 12, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2004DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance